Skip to content
Telehealth Graded
State guide

North Dakota Medicaid and GLP-1s

North Dakota does not just set criteria, it sets an order. The sleep-apnea route to tirzepatide requires six months of documented pharmacotherapy with semaglutide first, and if that is not tolerated, phentermine. The cardiovascular route to Wegovy requires escalating to 2 mg of Ozempic first. Meanwhile four older obesity drugs are covered with no prior authorization at all, on a diagnosis code alone.

Every source on this page was read first-hand in September 2026, and each one below carries the date printed on the document itself.

1
document cited
9
sourced facts
1
primary source

What changed, and what the document says

  1. Four obesity drugs, no authorization

    Covered

    The old oral agents are covered on a diagnosis code, with nothing else asked.

    “The following drugs are covered without prior authorization by submitting a corresponding”

    Medical Services Division, North Dakota Department of Health and Human Services — Version 2026.6, Effective: July 31, 2026

  2. And they are named

    Covered

    A short, specific list — no GLP-1 appears on it.

    “phentermine, bupropion, naltrexone, topiramate”

    Medical Services Division, North Dakota Department of Health and Human Services — Version 2026.6, Effective: July 31, 2026

  3. Six months of semaglutide before tirzepatide

    Not covered

    This is the requirement that makes North Dakota different. The cheaper drug has to be tried first, and for half a year.

    “The member must have documentation of participation in a comprehensive weight”

    Medical Services Division, North Dakota Department of Health and Human Services — Version 2026.6, Effective: July 31, 2026

  4. The program, spelled out

    Not covered

    Behavior, diet, activity and a drug, all four, for at least six months.

    “physical activity, and pharmacotherapy for at least 6 months with semaglutide.”

    Medical Services Division, North Dakota Department of Health and Human Services — Version 2026.6, Effective: July 31, 2026

  5. An Ozempic escalation before Wegovy

    Conditions apply

    The same logic on the cardiovascular side: the diabetes product has to be tolerated at full dose before the obesity-labeled one is authorized.

    “If the member qualifies for Wegovy injection, a dose escalation to 2mg of Ozempic injection”

    Medical Services Division, North Dakota Department of Health and Human Services — Version 2026.6, Effective: July 31, 2026

  6. A year on injections before tablets

    Conditions apply

    The oral form is treated as the last resort, not the convenient one.

    “Wegovy tablets: The member must have failed a 12-month trial of semaglutide injection, as”

    Medical Services Division, North Dakota Department of Health and Human Services — Version 2026.6, Effective: July 31, 2026

  7. Six months of CPAP first

    Conditions apply

    The sleep-apnea route also requires the machine to have been tried and failed, with a fresh index to prove it.

    “The member must have failed a 6-month trial of continuous positive airway pressure (CPAP)”

    Medical Services Division, North Dakota Department of Health and Human Services — Version 2026.6, Effective: July 31, 2026

  8. Cost decides which tirzepatide

    Context

    Where more than one product would qualify, the state names price as the tiebreaker in writing.

    “If the member qualifies for tirzepatide, the most cost-effective tirzepatide product will be”

    Medical Services Division, North Dakota Department of Health and Human Services — Version 2026.6, Effective: July 31, 2026

  9. Diabetes disqualifies you from this route

    Conditions apply

    The sleep-apnea pathway is closed to people with type 2 diabetes, who are routed to the diabetes criteria instead.

    “The member does not have diabetes type II”

    Medical Services Division, North Dakota Department of Health and Human Services — Version 2026.6, Effective: July 31, 2026

Which of these companies serve North Dakota?

Of the 242 companies we grade, 25 publish a list of the states they are licensed in. We checked 214 more and found no such list on any page we read; 3 we have not checked either way.

15 of those lists name North Dakota: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Trimi, HumeCare+, Rx.com, Mojoon and Peak Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Sources

Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026, the same session as the rest of this page.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.